Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 18368
Corporate User License Price USD 750
Corporate User License Price INR 55103
Site License Price USD 500
Site License Price INR 36735
Request a Quote

Report Title

Amgen Inc (AMGN) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Amgen Inc (AMGN) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Amgen Inc (AMGN) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Amgen Inc (AMGN) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells its products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by television advertising, direct-to-consumer print and multi-channel marketing. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc (AMGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note : Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Amgen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Amgen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Amgen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Amgen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Amgen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Amgen Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Gamida Cell Raises USD 10 Million In Series E Financing 12

Partnerships 14

Biocartis Enters into Development Agreement with Amgen 14

Biocartis Enters into Co-Development Agreement with Amgen 15

Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 16

Adaptive Biotech Enters into Agreement with Amgen 17

Biocartis Partners with Amgen 18

Exosome Diagnostics Enters into Agreement with Amgen 19

Flatiron Health Partners with Amgen 20

Biocartis Enters into Agreement with Amgen 21

Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 22

Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 23

Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 24

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 25

KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 26

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 27

Dako Enters Into Co-Development Agreement With Amgen 28

Dako Enters Into Co-Development Agreement With Amgen 29

Merger 30

AstraZeneca Rumored To Merge With Amgen 30

Amgen Enters into Licensing Agreement with Unilife 31

Debt Offering 32

Amgen Raises USD1 Billion in Public Offering of 3.2% Notes Due 2027 32

Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 34

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2019 36

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2024 38

Amgen Raises USD600 Million in Public Offering of Floating Notes Due 2017 40

Amgen Raises USD250 Million in Public Offering of Floating Notes Due 2019 42

Amgen Raises USD850 Million in Public Offering of Notes Due 2017 44

Acquisition 46

Amgen Completes Acquisition Of Decode Genetics, Human Genetics Company, For USD 401 Million 46

Amgen Inc-Key Competitors 48

Amgen Inc-Key Employees 49

Amgen Inc-Locations And Subsidiaries 51

Head Office 51

Other Locations & Subsidiaries 51

Joint Venture 57

Recent Developments 58

Strategy And Business Planning 58

Apr 10, 2018: Amgen Announces Rhode Island Will Be Location Of First US Next-Generation Biomanufacturing Plant 58

Jun 02, 2017: Amgen Showcases A Legacy Of Science, Innovation And Collaboration In Cambridge 59

Financial Announcements 60

Jul 26, 2018: Amgen reports second quarter 2018 Financial Results 60

Apr 24, 2018: Amgen Announces First Quarter 2018 Financial Results 63

Feb 01, 2018: Amgen Reports Fourth Quarter And Full Year 2017 Financial Results 65

Oct 25, 2017: Amgen Reports Third Quarter 2017 Financial Results 68

Jul 25, 2017: Amgen Reports Second Quarter 2017 Financial Results 70

Apr 26, 2017: Amgen Reports First Quarter 2017 Financial Results 72

Feb 02, 2017: Amgen Reports Fourth Quarter And Full Year 2016 Financial Results 75

Corporate Communications 78

Jul 26, 2018: Amgen Announces Succession Plans For Two Executive Officers 78

Dec 11, 2017: Amgen Foundation Pledges Up To USD 500,000 In Relief To Victims Of The Southern California Wildfires 79

Oct 24, 2017: Amgen Announces Appointment Of Wanda M. Austin To Board Of Directors 80

Sep 22, 2017: Amgen Foundation Pledges Up To USD 5 Million To Hurricane Maria Relief Efforts 81

Feb 03, 2017: Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors 82

Government and Public Interest 83

Jul 11, 2017: Amgen And QB3@953 Announce Winners Of The Amgen Golden Ticket 83

Other Significant Developments 84

Mar 08, 2018: Amgen Announces Final Results Of Tender Offer 84

Mar 06, 2018: Amgen Announces Preliminary Results Of Tender Offer 85

Sep 25, 2017: Amgen Provides Update On Hurricane Maria 86

Mar 29, 2017: Amgen Enters into Agreement with Inovalon and Avalere to Engage Value-based Contracting Opportunities 87

Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance 88

Appendix 89

Methodology 89

About GlobalData 89

Contact Us 89

Disclaimer 89

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Amgen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Amgen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Amgen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Amgen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Amgen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Amgen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Amgen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Amgen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Amgen Inc, Medical Equipment, Key Facts, 2017 2

Amgen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Amgen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Amgen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Amgen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Amgen Inc, Deals By Market, 2012 to YTD 2018 9

Amgen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Gamida Cell Raises USD 10 Million In Series E Financing 12

Biocartis Enters into Development Agreement with Amgen 14

Biocartis Enters into Co-Development Agreement with Amgen 15

Adaptive Biotechnologies Enters into Agreement with Amgen for Multiple Myeloma 16

Adaptive Biotech Enters into Agreement with Amgen 17

Biocartis Partners with Amgen 18

Exosome Diagnostics Enters into Agreement with Amgen 19

Flatiron Health Partners with Amgen 20

Biocartis Enters into Agreement with Amgen 21

Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 22

Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 23

Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 24

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 25

KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 26

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 27

Dako Enters Into Co-Development Agreement With Amgen 28

Dako Enters Into Co-Development Agreement With Amgen 29

AstraZeneca Rumored To Merge With Amgen 30

Amgen Enters into Licensing Agreement with Unilife 31

Amgen Raises USD1 Billion in Public Offering of 3.2% Notes Due 2027 32

Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 34

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2019 36

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2024 38

Amgen Raises USD600 Million in Public Offering of Floating Notes Due 2017 40

Amgen Raises USD250 Million in Public Offering of Floating Notes Due 2019 42

Amgen Raises USD850 Million in Public Offering of Notes Due 2017 44

Amgen Completes Acquisition Of Decode Genetics, Human Genetics Company, For USD 401 Million 46

Amgen Inc, Key Competitors 48

Amgen Inc, Key Employees 49

Amgen Inc, Other Locations 51

Amgen Inc, Subsidiaries 53

Amgen Inc, Joint Venture 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Amgen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand